Takeda Pharmaceutical Co (FRA:TKD) Total Liabilities: €44,050 Mil (As of Mar. 2026)


FRA:TKD Takeda Pharmaceutical Co Ltd FRA:TKD
64 GF Score
Price €28.76
GF Value €24.17
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Takeda Pharmaceutical Co Total Liabilities?

Takeda Pharmaceutical Co FRA:TKD -2.14% 64 Total Liabilities is €44,050 Mil as of Mar. 2026. GuruFocus rates FRA:TKD with a GF Score™ of 64/100 and a GF Value™ of €24.17 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Takeda Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2026 was €44,050 Mil.

Takeda Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2025 (€42,285.77 Mil) to Dec. 2025 (€42,529.84 Mil) and increased from Dec. 2025 (€42,529.84 Mil) to Mar. 2026 (€44,049.80 Mil).

Takeda Pharmaceutical Co's annual Total Liabilities declined from Mar. 2024 (€48,111.54 Mil) to Mar. 2025 (€45,378.01 Mil) and declined from Mar. 2025 (€45,378.01 Mil) to Mar. 2026 (€44,049.80 Mil).

Takeda Pharmaceutical Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Takeda Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co Total Liabilities Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57,388.69 53,127.69 48,111.54 45,378.01 44,049.80

Takeda Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45,378.01 42,835.03 42,285.77 42,529.84 44,049.80
FRA:TKD
64GF Score
Takeda Pharmaceutical Co Ltd FRA:TKD
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takeda Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Takeda Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=15438.003+(23819.698+3862.753
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+146.112+783.235+0)
=44,050

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=84555.233-40505.432
=44,050

Takeda Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=15438.003+(23819.698+3862.753
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+146.112+783.235+0)
=44,050

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=84555.233-40505.432
=44,050

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €44,050 Mil mean?
Takeda Pharmaceutical Co (FRA:TKD) has a Total Liabilities of €44,050 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Total Liabilities too high?
Takeda Pharmaceutical Co's current Total Liabilities is €44,050 Mil. Overall, Takeda Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Total Liabilities compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Total Liabilities of €44,050 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Total Liabilities is €44,050 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (FRA:TKD) is currently considered Modestly Overvalued. The stock's GF Value™ is €24.17, compared to a current price of €28.76 — trading 19% above its estimated fair value. The current Total Liabilities is €44,050 Mil. Takeda Pharmaceutical Co's overall GF Score™ is 64/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Takeda Pharmaceutical Co (FRA:TKD), the current Total Liabilities is €44,050 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takeda Pharmaceutical Co (FRA:TKD) Overvalued in 2026?

Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued. The current stock price of €28.76 is trading 19% above its estimated GF Value™ of €24.17. GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for FRA:TKD:

  • Total Liabilities: €44,050 Mil
  • GF Value™: €24.17 vs. price of €28.76 (19% above fair value)
  • GF Score™: 64/100 with 9 warning signs

No single metric tells the full story. See the FRA:TKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takeda Pharmaceutical Co Business Description

Address 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
64GF Score

Get the complete analysis for FRA:TKD

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.76
Price
€24.17
GF Value